Randomized trial data on pericardial diseases are scarce, but a number of new studies are moving the management of these conditions from empirically-based to evidence-based medicine. Massimo Imazio and colleagues show how the emerging data and the first guidelines for pericardial disease can be used to tailor management to the individual patient.
- Massimo Imazio
- Antonio Brucato
- Yehuda Adler
